AVROBIO, Inc.
USD1.40
-0.02 (-1.41%)
CEO
Erik John Ostrowski
IPO Date
2018-06-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.43
Prev. Close
$1.42
Day Low
$1.38
Day High
$1.44
52W Low
$1.38
52W High
$19.80
Market Cap
$0.01B
Volume
0.20M
| -11.8 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 50.6% | -108.7% | -0.05 | 0.76 | -1.4 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 70.5% | -68.2% | -0.13 | 4.73 | -1.0 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 59.7% | -27.2% | -0.07 | 6.95 | -18.5 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -47.1% | -44.1% | 0.00 | 16.09 | -4.2 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -39.2% | -36.4% | 0.00 | 13.96 | -7.6 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -37.9% | -34.7% | 0.00 | 12.26 | -8.5 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -554.2% | -265.6% | 0.00 | 2.40 | -40.0 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -105.5% | -86.4% | 0.00 | 6.03 | -160.1 |
| -5.0 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -7.1% | -6.9% | 0.00 | 29.15 | -3.9 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -7.0% | -6.8% | 0.01 | 25.60 | -4.6 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -5.3% | -5.1% | 0.01 | 22.92 | -4.8 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -8.8% | -8.1% | 0.02 | 12.65 | -13.8 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -11.8% | -10.5% | 0.02 | 9.39 | -6.3 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -7.6% | -6.5% | 0.02 | 7.21 | -4.6 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -17.1% | -16.5% | 0.05 | 26.17 | -0.9 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 9.3% | -20.0% | -0.05 | 0.76 | -1.9 |